Study of Real World Anticoagulation and Antiplatelet Practice in Patients with Acute Coronary Syndrome Complicated with Atrial fibrillatio
Not Applicable
- Conditions
- Atrial fibrillation combined acute coronary syndrome
- Registration Number
- JPRN-UMIN000027356
- Lead Sponsor
- Juntendo University Department of Cardiovascular Medicine, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 460
Inclusion Criteria
Not provided
Exclusion Criteria
1) ACS caused by surgery, trauma, or coronary rebascularization (PCI or CABG) 2) Patients under 20years of age 3) Transient af after the onset of ACS is excluded 4) Patients considered inappropriatc for study participation by attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method #1 Major Bleeding according to International Soiety of Thrombosis and Hemostasis (ISTH) #2 MACCE (major adverse cardio-cerebral event): composite endpoint of death associated withACS/storoke and other cardiovascular (CV) deaths, non-fatal ACS and non-fatal stroke,and stent thrombosis
- Secondary Outcome Measures
Name Time Method 1) Death due to hemorrhage, 2) Cardiac death, CV death (cause of mortality) 3) Non-CV death (cause of death;final clinical diagnosis of death) 4) Bleeding